Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT05646316 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 428 participants |
| Active Locations | 52 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | March 27, 2026 (3 weeks ago) |
As of April 18, 2026: Clinical trial NCT05646316 is currently recruiting participants. This clinical trial study for endometrial cancer is actively seeking new participants at 52 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05646316 is actively recruiting participants as of April 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05646316 was last updated 3 weeks ago (March 27, 2026). HelloStudys verifies this status automatically.